Overview
- The Nasdaq-listed firm, formerly Portage Biotech, plans to purchase about $100 million in Toncoin to anchor a corporate digital asset treasury.
- Funding comprises a $38.2 million private placement plus a $35 million BitGo Prime loan collateralized by TON, repayable in six months.
- The ticker is scheduled to switch from PRTG to ATON on Sept. 4, with the private placement expected to close around Sept. 5 subject to customary conditions.
- Brittany Kaiser has been appointed chief executive officer, and Enzo Villani will serve as executive chairman as the company pivots to digital assets.
- Shares rose roughly 14–15% after the announcement, as the firm outlined TON staking and validation plans and Telegram mini app incubation in a landscape that includes VERB accumulating a large TON position.